Benitec Biopharma Inc. - 10-Q Filing
Benitec Biopharma reports quarterly results for period ended September 30, 2026, with 36.1 million shares outstanding as of November 9, 2026.
Tickers: $BNTC
More Regulatory news
- COMMVAULT SYSTEMS INC - 8-K Filing
- Indaptus Therapeutics, Inc. - 10-Q Filing
- Katapult Holdings, Inc. - 10-Q Filing
- GOODYEAR TIRE & RUBBER CO /OH/ - 8-K Filing
- BIO KEY INTERNATIONAL INC - 8-K Filing
- Loop Industries, Inc. - 8-K Filing
- Cineverse Corp. - 10-Q Filing
- FRP HOLDINGS, INC. - 10-Q Filing
- Aardvark Therapeutics, Inc. - 8-K Filing
- Cineverse Corp. - 8-K Filing